Phosphorylation of triciribine is necessary for activity against HIV type 1.

Triciribine (TCN) is a tricyclic nucleoside with known antineoplastic and antiviral activity. It is a potent and selective inhibitor of HIV-1 and HIV-2, including strains known to be resistant to AZT or TIBO. TCN is phosphorylated to its 5'-monophosphate (TCN-P) by intracellular adenosine kinase (AK), but is not converted to di- or triphosphates. We now report that 5'-phosphorylation is requisite for the activity of TCN against HIV-1. CEM cells incubated with TCN at concentrations ranging from 0.1 to 330 microM gave intracellular TCN-P concentrations from 27 to 775 microM, respectively. There was no difference in the amount of intracellular TCN-P detected in uninfected compared with HIV-1-infected CEM cells. The antiviral effect of TCN against HIV-1 was strongly antagonized by the AK inhibitor 5-iodotubercidin (ITu). In contrast, TCN and ITu only exhibited additive cytotoxicity. The 5'-deoxy analog of TCN, which cannot be phosphorylated, had no antiviral effect against HIV-1 at a concentration more than 100 times higher than the IC50 of TCN. Similarly, TCN was not active against HIV-1 in an AK-deficient cell line (AA-2) at concentrations shown to inhibit the virus by >95% in CEM cells. Consistent with its AK-deficient phenotype, this cell line phosphorylated TCN to only 3% of the extent observed in CEM cells. We conclude that TCN must be phosphorylated to TCN-P for activity against HIV-1.

[1]  C. Cheng‐Mayer,et al.  Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  U. Schubert,et al.  Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments , 1994, Journal of virology.

[3]  W. Parker,et al.  Dual mechanisms of inhibition of DNA synthesis by triciribine. , 1990, Cancer research.

[4]  A. Greenway,et al.  Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines , 1995, Journal of virology.

[5]  S. Massia,et al.  Inhibition of CCRF-CEM human leukemic lymphoblasts by triciribine (tricyclic nucleoside, TCN, NSC-154020). Accumulation of drug in cells and comparison of effects on viability, protein synthesis and purine synthesis. , 1989, Biochemical pharmacology.

[6]  M. Prichard,et al.  Analysis of combinations of antiviral drugs and design of effective multidrug therapies. , 1996, Antiviral therapy.

[7]  K. Jeang,et al.  Modulation of Sp1 Phosphorylation by Human Immunodeficiency Virus Type 1 Tat , 1998, Journal of Virology.

[8]  R. Yolken,et al.  Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1 , 1997, Schizophrenia Research.

[9]  D. Trono,et al.  HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator , 1995, Cell.

[10]  N. Hernandez,et al.  The HIV-1 Inducer of Short Transcripts Activates the Synthesis of 5,6-Dichloro-1-β-d-benzimidazole-resistant Short Transcripts in Vitro * , 1998, The Journal of Biological Chemistry.

[11]  M. Skinner,et al.  Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines , 1988, The Journal of experimental medicine.

[12]  H. Cottam,et al.  New adenosine kinase inhibitors with oral antiinflammatory activity: synthesis and biological evaluation. , 1993, Journal of medicinal chemistry.

[13]  M. Gonda,et al.  Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. , 1987, AIDS research and human retroviruses.

[14]  A. Levitzki,et al.  Tyrosine kinase inhibition: an approach to drug development. , 1995, Science.

[15]  M. Moos,et al.  Separation of 5'-ribonucleoside monophosphates by ion-pair reverse-phase high-performance liquid chromatography. , 1980, Analytical biochemistry.

[16]  J. R. Roti Roti,et al.  Effects of the tricyclic nucleoside 6-amino-4-methyl-8-(beta-D-ribofuranosyl)- pyrrolo[4,3,2-de]pyrimido[4,5-c]pyridazine on the viability and cell cycle distribution of L1210 cells in vitro. , 1985, Cancer research.

[17]  F. Bushman,et al.  HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase , 1995, Cell.

[18]  L. Townsend,et al.  The synthesis of 6-amino-4-methyl-8-(β-D-ribofuranosyl) (4-H,8-H)pyrrolo-[4,3,2-de]pyrimido[4,5-c]pyridazine, a new tricyclic nucleoside , 1971 .

[19]  A. Abo,et al.  The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix , 1997, Journal of virology.

[20]  M. Prichard,et al.  A three-dimensional model to analyze drug-drug interactions. , 1990, Antiviral research.

[21]  R. Pauwels,et al.  A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates. , 1991, Antiviral research.

[22]  C. Chang,et al.  Phosphorylation of "tricyclic nucleoside" by adenosine kinases from L1210 cells and HEp-2 cells. , 1983, Biochemical pharmacology.

[23]  P. Nara,et al.  Quantitative infectivity assay for HIV-1 and -2 , 1988, Nature.

[24]  J Desmyter,et al.  Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. , 1988, Journal of virological methods.

[25]  J. Levy,et al.  The HIV‐1 nef gene product is associated with phosphorylation of a 46 kD cellular protein , 1992, AIDS.

[26]  B. Roques,et al.  Direct activation of protein phosphatase‐2A0 by HIV‐1 encoded protein complex NCp7:vpr , 1997, FEBS letters.

[27]  E. Wingender,et al.  The Human Immunodeficiency Virus Type 1 Encoded Vpu Protein is Phosphorylated by Casein Kinase-2 (CK-2) at Positions Ser52 and Ser56 within a Predicted α-Helix-Turn-α-Helix-Motif , 1994 .

[28]  R. K. Robins,et al.  Pyrrolopyrimidine nucleosides. IV. The synthesis of certain 4,5‐disubstituted‐7‐(β‐d‐ribofuranosyl)pyrrolo[2,3‐d]pyrimidines related to the pyrrolo[2,3‐d]pyrimidine nucleoside antibiotics , 1969 .

[29]  E. White,et al.  Activity of triciribine and triciribine-5'-monophosphate against human immunodeficiency virus types 1 and 2. , 1993, AIDS research and human retroviruses.

[30]  L. Montagnier,et al.  A rapid and simple colorimetric test for the study of anti-HIV agents. , 1988, AIDS research and human retroviruses.

[31]  J. Marsh,et al.  Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family , 1996, Journal of virology.

[32]  H. Lazarus,et al.  Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia , 1965, Cancer.

[33]  M. Harris,et al.  Protein Kinase C-mediated Phosphorylation of HIV-I Nef in Human Cell Lines* , 1997, The Journal of Biological Chemistry.

[34]  D. Santi,et al.  High-pressure liquid chromatography--ultraviolet analysis of intracellular nucleotides. , 1982, Analytical biochemistry.

[35]  K. Nye,et al.  The effects of CD3, CD4 and CD28 signaling on lymphocytes during human immunodeficiency virus‐1 infection , 1997, European journal of immunology.

[36]  Mark S. Boguski,et al.  Proteins regulating Ras and its relatives , 1993, Nature.

[37]  T. Smithgall,et al.  Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  F. Grummt,et al.  Drastic rise of intracellular adenosine(5')tetraphospho(5')adenosine correlates with onset of DNA synthesis in eukaryotic cells. , 1984, European journal of biochemistry.

[39]  C. Kowal,et al.  Characterization of oxyphenarsine as a potential antiviral agent for AIDS. , 1992, AIDS research and human retroviruses.

[40]  C. Cheng‐Mayer,et al.  The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. , 1997, Immunity.

[41]  K. Tracey,et al.  The Critical Role of p38 MAP Kinase in T Cell HIV-1 Replication , 1997, Molecular medicine.

[42]  R. Parks,et al.  N-Methylformycins. Reactivity with adenosine deaminase, incorporation into intracellular nucleotides of human erythrocytes and L 1210 cells and cytotoxicity to L 1210 cells. , 1979, Biochemical pharmacology.